Stuttgart - Delayed Quote EUR

Vidac Pharma Holding Plc (T9G.SG)

Compare
0.6500
-0.0100
(-1.52%)
At close: 7:59:54 PM GMT+1
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
1,210.0000
1,210.0000
609.0000
Operating Income
-1,210.0000
-1,210.0000
-609.0000
Net Non Operating Interest Income Expense
-65.0000
-65.0000
-34.0000
Pretax Income
-1,275.0000
-1,275.0000
-643.0000
Net Income Common Stockholders
-1,275.0000
-1,275.0000
-643.0000
Diluted NI Available to Com Stockholders
-1,275.0000
-1,275.0000
-643.0000
Basic EPS
-0.00
--
-0.01
Diluted EPS
-0.00
--
-0.01
Basic Average Shares
52,821,074.0000
--
53,815.1420
Diluted Average Shares
52,821,074.0000
--
53,815.1420
Total Operating Income as Reported
-1,210.0000
-1,210.0000
-609.0000
Total Expenses
1,210.0000
1,210.0000
609.0000
Net Income from Continuing & Discontinued Operation
-1,275.0000
-1,275.0000
-643.0000
Normalized Income
-1,275.0000
-1,275.0000
-643.0000
Net Interest Income
-65.0000
-65.0000
-34.0000
EBIT
-1,210.0000
-1,210.0000
-609.0000
EBITDA
-1,209.0000
-1,209.0000
-608.0000
Reconciled Depreciation
1.0000
1.0000
1.0000
Net Income from Continuing Operation Net Minority Interest
-1,275.0000
-1,275.0000
-643.0000
Normalized EBITDA
-1,209.0000
-1,209.0000
-608.0000
12/31/2022 - 8/11/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers